Antifungal prophylaxis is effective against murine invasive pulmonary aspergillosis

Antimicrob Agents Chemother. 2006 Aug;50(8):2895-6. doi: 10.1128/AAC.00299-06.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amphotericin B / administration & dosage*
  • Amphotericin B / therapeutic use
  • Animals
  • Antifungal Agents / administration & dosage*
  • Antifungal Agents / therapeutic use
  • Aspergillosis / prevention & control*
  • Aspergillus fumigatus / drug effects
  • Drug Administration Schedule
  • Drug Combinations
  • Injections, Intravenous
  • Lung Diseases, Fungal / drug therapy*
  • Lung Diseases, Fungal / microbiology
  • Lung Diseases, Fungal / pathology
  • Lung Diseases, Fungal / prevention & control*
  • Mice
  • Mice, Inbred BALB C
  • Peptides, Cyclic / administration & dosage
  • Peptides, Cyclic / therapeutic use
  • Phosphatidylcholines / administration & dosage
  • Phosphatidylcholines / therapeutic use
  • Phosphatidylglycerols / administration & dosage
  • Phosphatidylglycerols / therapeutic use
  • Time Factors

Substances

  • Antifungal Agents
  • Drug Combinations
  • Peptides, Cyclic
  • Phosphatidylcholines
  • Phosphatidylglycerols
  • liposomal amphotericin B
  • Amphotericin B